Barbiturate withdrawal is when sudden stopping of barbiturate drugs causes severe illness and withdrawal. This especially happens when infusions are given in the hospital and abruptly stopped. What are the Barbiturate withdrawal symptoms? In the First 12-16 hours: There is an observable improvement. After 16 hours: nausea, vomiting, anxiety, tremors, abdominal cramps, orthostatic hypotension, restlessness. […]
Etomidate mechanism of action is shown here. The GABAA receptor plays a central role in the etomidate mechanism of action Etomidate exerts its effects on the receptor by binding directly to a specific site or sites on the protein and allosterically enhancing the apparent affinity of GABA for its receptor. At much higher concentrations etomidate
This butorphanol drug class was introduced about 25-30 years back. That was the era of morphine, pethidine, so it did not gain much acceptance. But now re-introduced, has become a major “find”. It is a classical example of “resurrection”. Butorphanol is a morphinan derivative with spectrum of activity almost like pentazocine, only that it is 20
For the Alveolar partial pressure of oxygen we see, Increasing the inspired concentration (F1) of an anesthetic agent increases the alveolar concentration (FA). A 75% nitrous oxide (N20) in oxygen mixture increases the FI/FA ratio of N2O. The amount of nitrous oxide absorbed will be greater than the nitrogen given out in the alveoli, hence
The midazolam half life elimination of IM administration is comparable to that observed following the IV administration. Midazolam is approximately 97% plasma protein-bound in normal subjects. In patients with chronic renal failure, the free fraction of drug in plasma can be significantly higher than in healthy adults. In animals and humans, Midazolam has shown to
In patients with acute renal failure, total body clearance is lower and the elimination half-life, while considering midazolam duration of action becomes longer than in patients with normal kidney function. In patients with impaired kidney function, the excretion of 1-hydroxymethyl midazolam glucuronide, the major metabolite of midazolam, is impaired. In healthy children aged 1 year
Two classes of drugs exist GP IIb/IIIa inhibitors that inhibit these platelet effects at the level of the glycoprotein (GP) IIb/IIIa receptor on the platelet surface membrane. The first group are the thienopyridines (clopidogrel and ticlopidine). Current treatments for acute coronary syndromes including unstable angina and non-ST-elevation myocardial infarction now include agents aimed at inhibiting platelet activation,
Etomidate pharmacology is studied using following points. In etomidate pharmacology we find that Etomidate is a potent, direct cerebral vasoconstrictor. It decreases cerebral blood flow and CMRO2 in an independent manner. The cerebral metabolic effects of etomidate are secondary to its effect on neuronal function. As a result, previously increase ICP is lowered by etomidate
The depth of propofol sedation increases in a dose dependent manner. The short context-sensitive half-time of propofol, even with prolonged periods of infusion, make this a readily titratable drug for production of IV sedation. The prompt recovery without residual sedation and low incidence of nausea and vomiting make propofol particularly well suited to ambulatory conscious
The pharmacodynamics of inhaled anesthetics is discussed here in detail. The action of inhalation agents are as follows: I. Pulmonary effects 2. Cardiovascular effects 3. Metabolism 4. Toxicity Pulmonary Effects: For pharmacodynamics of inhaled anesthetics , the pulmonary effects of inhalation agents are many and important as this is the portal of entry. There are
